AP05261CP-N SPARC / Osteonectin Control Peptide

Search for all "SPARC / Osteonectin"

50 µg / €230.00
Please visit the country specific website of OriGene Technologies or contact your local Distributor to buy this product.

Quick Overview

anti SPARC / Osteonectin

AP05261CP-N

Product Description for SPARC / Osteonectin

anti SPARC / Osteonectin.
Properties: Control Peptide
Presentation: Purified

Properties for SPARC / Osteonectin

Product Category Control Peptides
Quantity 50 µg
Synonyms BM-40, Basement-membrane protein 40, ON, Secreted protein acidic and rich in cysteine
Presentation Purified
Clonality Polyclonal
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer OriGene Technologies GmbH
Material safety datasheet MSDS for Polyclonal Antibodies (de)

Datasheet Extract

Immunogen
Swiss Prot Num:
P09486
GeneID:
6678
Application Incubate antibody neat with at least a 50 fold stoichiometric excess of blocking peptide at 37°C for 20 minutes (molecular weights of peptide and antibody are ~2.5 kDa and ~160 kDa, respectively). Antibody can then be diluted to a concentration suitable for Western blot.
Example: 10 µl or 10 µg of rabbit anti-SPARC is added to 10 µg of blocking peptide for a total volume of 20 µl. The mixture is allowed to incubate for 20 minutes at 37°C prior to dilution in suitable buffer (for Western blot, etc.).
Background SPARC is a key factor in cell-matrix interactions and possibly tumour aggressiveness. The SPARC gene, which encodes a multifunctional glycoprotein with roles in tissue development, remodelling and fibrosis. A regulator of cell-extracellular matrix (ECM) interactions, SPARC represents a major factor in the ECM remodelling occurring during tumour invasion. in silico analysis reveals 4 UTR-SNPs located in the 3 -UTR of the SPARC gene, corresponding to 1474 g a, 1551 g c, 1922 t g and 2072 c t changes, which are significantly associated with tumoral state of the tissue. Of all hits, the 2072 SPARC polymorphism had the best association with cancer. SPARC therefore is a gene involved in a number of diseases including rheumatoid arthritis, scleroderma, tumor development and metastasis. SPARC variants have been detected in tumour samples of patients with acute myeloblastic leukemia (AML).
Concentration Lot specific
Storage Store at -20°C.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
Format
Buffer System:
Phosphate buffered saline containing 0.08% sodium azide
Purity:
Purified
State:
Liquid purified peptide
Purified
Specificity
Specificity:
Control peptide for antibody AP05261PU-N only.
Gene ID 6678

Accessory Products

  • LinkedIn